{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,30]],"date-time":"2026-09-30T13:54:51Z","timestamp":1790776491896,"version":"4.1.0"},"reference-count":83,"publisher":"MDPI AG","issue":"4","license":[{"start":{"date-parts":[[2012,3,27]],"date-time":"2012-03-27T00:00:00Z","timestamp":1332806400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/3.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Nutrients"],"abstract":"<jats:p>Celiac disease (CD), a common heritable chronic inflammatory condition of the small intestine caused by permanent intolerance to gluten\/gliadin (prolamin), is characterized by a complex interplay between genetic and environmental factors. Developments in proteomics have provided an important contribution to the understanding of the biochemical and immunological aspects of the disease and the mechanisms involved in toxicity of prolamins. It has been demonstrated that some gliadin peptides resistant to complete proteolytic digestion may directly affect intestinal cell structure and functions by modulating gene expression and oxidative stress. In recent years, the creation of the two research fields Nutrigenomics and Nutrigenetics, has enabled the elucidation of some interactions between diet, nutrients and genes. Various dietary components including long chain \u03c9-3 fatty acids, plant flavonoids, and carotenoids have been demonstrated to modulate oxidative stress, gene expression and production of inflammatory mediators. Therefore their adoption could preserve intestinal barrier integrity, play a protective role against toxicity of gliadin peptides and have a role in nutritional therapy of celiac disease.<\/jats:p>","DOI":"10.3390\/nu4040243","type":"journal-article","created":{"date-parts":[[2012,3,27]],"date-time":"2012-03-27T11:09:42Z","timestamp":1332846582000},"page":"243-257","update-policy":"https:\/\/doi.org\/10.3390\/mdpi_crossmark_policy","source":"Crossref","is-referenced-by-count":132,"title":["Celiac Disease, Inflammation and Oxidative Damage: A Nutrigenetic Approach"],"prefix":"10.3390","volume":"4","author":[{"given":"Gianna","family":"Ferretti","sequence":"first","affiliation":[{"name":"Department of Odontostomatologic and Specialistic Clinics Sciences, Polytechnic University of Marche, via Ranieri 65, 60100 Ancona, Italy"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tiziana","family":"Bacchetti","sequence":"additional","affiliation":[{"name":"Department of Life and Environmental Sciences, Polytechnic University of Marche, via Ranieri 65, 60100 Ancona, Italy"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Simona","family":"Masciangelo","sequence":"additional","affiliation":[{"name":"Department of Life and Environmental Sciences, Polytechnic University of Marche, via Ranieri 65, 60100 Ancona, Italy"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Letizia","family":"Saturni","sequence":"additional","affiliation":[{"name":"Ibero-American University Foundation\u2014FUNIBER, via Ranieri 65, 60100 Ancona, Italy"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1968","published-online":{"date-parts":[[2012,3,27]]},"reference":[{"key":"ref_1","doi-asserted-by":"crossref","first-page":"595","DOI":"10.1016\/j.coi.2005.09.015","article-title":"Is celiac disease an autoimmune disorder?","volume":"17","author":"Sollid","year":"2005","journal-title":"Curr. Opin. Immunol."},{"key":"ref_2","first-page":"864","article-title":"Recent advances in coeliac disease","volume":"36","author":"West","year":"2006","journal-title":"Gut"},{"key":"ref_3","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1094\/CCHEM-85-1-0001","article-title":"The biochemical basis of celiac disease","volume":"85","author":"Wieser","year":"2008","journal-title":"Cereal Chem."},{"key":"ref_4","doi-asserted-by":"crossref","first-page":"685","DOI":"10.1515\/CCLM.2005.117","article-title":"\u201cCoelionomics\u201d: Towards understanding the molecular pathology of coeliac disease","volume":"43","author":"Diosdado","year":"2005","journal-title":"Clin. Chem. Lab. Med."},{"key":"ref_5","doi-asserted-by":"crossref","first-page":"373","DOI":"10.1016\/j.bpg.2005.02.003","article-title":"Pathomechanisms in celiac disease","volume":"19","author":"Koning","year":"2005","journal-title":"Best Pract. Res. Clin. Gastroenterol."},{"key":"ref_6","doi-asserted-by":"crossref","first-page":"219","DOI":"10.1111\/j.0105-2896.2005.00294.x","article-title":"Innate and adaptive immunity: The Yin and Yang of celiac disease","volume":"206","author":"Jabri","year":"2005","journal-title":"Immunol. Rev."},{"key":"ref_7","doi-asserted-by":"crossref","first-page":"95","DOI":"10.1586\/epr.10.98","article-title":"Proteomic analysis in allergy and intolerance to wheat products","volume":"8","author":"Mamone","year":"2011","journal-title":"Expert Rev. Proteomics"},{"key":"ref_8","doi-asserted-by":"crossref","first-page":"408","DOI":"10.1111\/j.1365-2249.2005.02783.x","article-title":"The immune recognition of gluten in coeliac disease","volume":"140","author":"Ciccocioppo","year":"2005","journal-title":"Clin. Exp. Immunol."},{"key":"ref_9","doi-asserted-by":"crossref","first-page":"2275","DOI":"10.1126\/science.1074129","article-title":"Structural basis for gluten intolerance in celiac sprue","volume":"297","author":"Shan","year":"2002","journal-title":"Science"},{"key":"ref_10","doi-asserted-by":"crossref","first-page":"1078","DOI":"10.1136\/gut.2008.169052","article-title":"Coeliac disease-associated risk variants in TNFAIP3 and REL implicate altered NF-kappaB signalling","volume":"58","author":"Trynka","year":"2009","journal-title":"Gut"},{"key":"ref_11","doi-asserted-by":"crossref","first-page":"12390","DOI":"10.1073\/pnas.2135229100","article-title":"The HLA-DQ2 gene dose effect in celiac disease is directly related to the magnitude and breadth of gluten-specific T cell responses","volume":"100","author":"Vader","year":"2003","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"ref_12","doi-asserted-by":"crossref","first-page":"1112","DOI":"10.1016\/j.humpath.2010.10.010","article-title":"Gluten-dependent enteropathy and atypical human leukocyte antigen alleles","volume":"42","author":"Harmon","year":"2011","journal-title":"Hum. Pathol."},{"key":"ref_13","doi-asserted-by":"crossref","first-page":"469","DOI":"10.1016\/S0198-8859(03)00027-2","article-title":"European genetics cluster on celiac disease","volume":"64","author":"Karell","year":"2003","journal-title":"Hum. Immunol."},{"key":"ref_14","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1017\/S0007114509377867","article-title":"Inflammatory disease processes and interactions with nutrition","volume":"101","author":"Calder","year":"2009","journal-title":"Br. J. Nutr."},{"key":"ref_15","doi-asserted-by":"crossref","first-page":"696","DOI":"10.1016\/S0016-5085(03)01049-7","article-title":"Alterations of the intestinal tran sport and processing of gliadin peptides in celiac disease","volume":"125","author":"Candalh","year":"2003","journal-title":"Gastroenterology"},{"key":"ref_16","doi-asserted-by":"crossref","first-page":"537","DOI":"10.1016\/j.molmed.2010.09.003","article-title":"A genetic perspective on coeliac disease","volume":"16","author":"Trynka","year":"2010","journal-title":"Trends Mol. Med."},{"key":"ref_17","doi-asserted-by":"crossref","first-page":"243","DOI":"10.1007\/s007260170010","article-title":"Structure-activity relationships in coeliac-toxic gliadin peptides","volume":"21","author":"Cornell","year":"2001","journal-title":"Amino Acid"},{"key":"ref_18","doi-asserted-by":"crossref","first-page":"S738","DOI":"10.1097\/00005176-200406003-00011","article-title":"Dietary proteins and mechanismsof gastrointestinal diseases: Gliadin as a model","volume":"39","author":"Auricchio","year":"2004","journal-title":"J. Pediatr. Gastroenterol. Nutr."},{"key":"ref_19","doi-asserted-by":"crossref","first-page":"996","DOI":"10.1152\/ajpgi.00136.2002","article-title":"Intestinal digestive resistance of immunodominant gliadin peptides","volume":"283","author":"Hausch","year":"2002","journal-title":"Am. J. Physiol. Gastrointest. Liver Physiol."},{"key":"ref_20","first-page":"1","article-title":"Mechanism and basis for specificity of transglutaminasecatalyzede-(g-glutamyl) lysine bond formation","volume":"54","author":"Folk","year":"1983","journal-title":"Adv. Enzymol. Relat. Areas Mol. Biol."},{"key":"ref_21","doi-asserted-by":"crossref","first-page":"10","DOI":"10.1053\/j.gastro.2005.02.008","article-title":"Overview and pathogenesis of celiac disease","volume":"128","author":"Kagnoff","year":"2005","journal-title":"Gastroenterology"},{"key":"ref_22","doi-asserted-by":"crossref","first-page":"30","DOI":"10.1016\/S0140-6736(03)13803-2","article-title":"Association between innate response to gliadin and activation of pathogenic T cells in celiac disease","volume":"362","author":"Maiuri","year":"2003","journal-title":"Lancet"},{"key":"ref_23","doi-asserted-by":"crossref","first-page":"284","DOI":"10.1136\/gut.39.2.284","article-title":"Proteolytic degradation of intestinal mucosa extracellular matrix after lamina propria T cell activation","volume":"39","author":"Pender","year":"1996","journal-title":"Gut"},{"key":"ref_24","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.toxlet.2003.09.004","article-title":"Gliadin cytotoxicity and in vitro cell cultures","volume":"46","author":"Elli","year":"2003","journal-title":"Toxicol. Lett."},{"key":"ref_25","doi-asserted-by":"crossref","first-page":"247","DOI":"10.3109\/00365529609004874","article-title":"In vitro activities of A-gliadin related synthetic peptides: Damaging affect on the atrophic coeliac mucosa and activation of mucosal immune response in the treated coeliac mucosa","volume":"31","author":"Maiuri","year":"1996","journal-title":"Scand. J. Gastroenterol."},{"key":"ref_26","doi-asserted-by":"crossref","first-page":"747","DOI":"10.1136\/gut.2007.136366","article-title":"Mechanisms of epithelial translocation of the a2-gliadin-33mer in coeliac sprue","volume":"57","author":"Schumann","year":"2008","journal-title":"Gut"},{"key":"ref_27","doi-asserted-by":"crossref","first-page":"274","DOI":"10.1111\/j.1749-6632.2009.04032.x","article-title":"Pathways of gliadin transport in celiac disease","volume":"1165","author":"Heyman","year":"2009","journal-title":"Ann. N. Y. Acad. Sci."},{"key":"ref_28","doi-asserted-by":"crossref","first-page":"300","DOI":"10.1136\/gut.2008.169656","article-title":"Endocytotic segregation of gliadin peptide 31\u201349 in enterocytes","volume":"59","author":"Zimmer","year":"2010","journal-title":"Gut"},{"key":"ref_29","doi-asserted-by":"crossref","first-page":"311","DOI":"10.1136\/gut.2009.183608","article-title":"Lysosomal accumulation of gliadin p31\u201343 peptide induces oxidative stress and tissue transglutaminase-mediated PPARgamma downregulation in intestinal epithelial cells and coeliac mucosa","volume":"59","author":"Luciani","year":"2010","journal-title":"Gut"},{"key":"ref_30","doi-asserted-by":"crossref","unstructured":"Rivabene, R., Mancini, E., and de Vincenzi, M. (1453). In vitro cytotoxic effect of wheat gliadin-derived peptides on the Caco-2 intestinal cell line is associated with intracellular oxidative imbalance: Implications for coeliac disease. Biochim. Biophys. Acta, 152\u2013160.","DOI":"10.1016\/S0925-4439(98)00095-7"},{"key":"ref_31","doi-asserted-by":"crossref","first-page":"380","DOI":"10.1136\/gut.49.3.380","article-title":"Intraepithelial and lamina propria lymphocytes show distinct patterns of apoptosis whereas both populations are active in Fas based cytotoxicity in coeliac disease","volume":"49","author":"Ciccocioppo","year":"2001","journal-title":"Gut"},{"key":"ref_32","doi-asserted-by":"crossref","first-page":"63","DOI":"10.1016\/S0300-483X(99)00223-1","article-title":"Induction of apoptosis in CaCo-2 cells by wheat gliadin peptides","volume":"145","author":"Giovannini","year":"2000","journal-title":"Toxicology"},{"key":"ref_33","doi-asserted-by":"crossref","first-page":"533","DOI":"10.1016\/S0887-2333(96)00042-2","article-title":"Inhibition of the cellular metabolism of Caco-2 cells by prolamin peptides from cereals toxic for coeliacs","volume":"10","author":"Giovannini","year":"1996","journal-title":"Toxicol. In Vitro"},{"key":"ref_34","doi-asserted-by":"crossref","first-page":"251","DOI":"10.1016\/0887-2333(94)00212-D","article-title":"Mytotoxic effect of prolamin-derived peptides on in vitro cultures of cell line Caco-2: Implications for coeliac disease","volume":"9","author":"Giovannini","year":"1994","journal-title":"Toxicol. In Vitro"},{"key":"ref_35","doi-asserted-by":"crossref","first-page":"331","DOI":"10.1016\/S0887-2333(02)00017-6","article-title":"In vitro cytotoxic effect of bread wheat gliadin on the LoVo human adenocarcinoma cell line","volume":"16","author":"Dolfini","year":"2002","journal-title":"Toxicol. In Vitro"},{"key":"ref_36","doi-asserted-by":"crossref","first-page":"703","DOI":"10.1016\/0016-5085(90)90958-4","article-title":"Gliadin challenge-induced jejunal prostaglandin E2 secretion in celiac disease","volume":"99","author":"Knutson","year":"1990","journal-title":"Gastroenterologist"},{"key":"ref_37","doi-asserted-by":"crossref","first-page":"1431","DOI":"10.1016\/j.clinbiochem.2009.06.009","article-title":"Antioxidant status and lipid peroxidation in small intestinal mucosa of children with celiac disease","volume":"42","year":"2009","journal-title":"Clin. Biochem."},{"key":"ref_38","doi-asserted-by":"crossref","first-page":"1058","DOI":"10.1136\/gut.29.8.1058","article-title":"Mucosal biotransformation rates in the small intestine of children","volume":"29","author":"Stahlberg","year":"1988","journal-title":"Gut"},{"key":"ref_39","doi-asserted-by":"crossref","first-page":"485","DOI":"10.1136\/gut.42.4.485","article-title":"Impairment of intestinal glutathione synthesis in patients with inflammatory bowel disease","volume":"42","author":"Sido","year":"1998","journal-title":"Gut"},{"key":"ref_40","doi-asserted-by":"crossref","first-page":"134","DOI":"10.1016\/j.cccn.2005.01.029","article-title":"Elevated expression of iNOS mRNA and protein in coeliac disease","volume":"356","author":"Daniels","year":"2005","journal-title":"Clin. Chim. Acta"},{"key":"ref_41","first-page":"29","article-title":"Presence of inducible nitric oxide synthase, nitrotyrosine, CD68, and CD14 in the small intestine in celiac disease","volume":"77","author":"Buurman","year":"1997","journal-title":"Lab. Invest."},{"key":"ref_42","first-page":"641","article-title":"The detection and localization of inducible nitric oxide synthase production in the small intestine of patients with coeliac disease","volume":"10","author":"Beckett","year":"1998","journal-title":"Eur. J. Gastroenterol. Hepatol."},{"key":"ref_43","doi-asserted-by":"crossref","first-page":"939","DOI":"10.1080\/003655298750026958","article-title":"Children with celiac disease express inducible nitric oxide synthase in the small intestine during gluten challenge","volume":"33","author":"Magnusson","year":"1998","journal-title":"Scand. J. Gastroenterol."},{"key":"ref_44","doi-asserted-by":"crossref","first-page":"319","DOI":"10.1152\/ajpgi.00324.2001","article-title":"Increased activity and expression of iNOS in human duodenal enterocytes from patients with celiac disease","volume":"283","author":"Murray","year":"2002","journal-title":"Am. J. Physiol. Gastrointest. Liver Physiol."},{"key":"ref_45","doi-asserted-by":"crossref","first-page":"1091","DOI":"10.1097\/00042737-200310000-00005","article-title":"Fasting plasma nitric oxide products in coeliac disease","volume":"15","author":"Murray","year":"2003","journal-title":"Eur. J. Gastroenterol. Hepatol."},{"key":"ref_46","doi-asserted-by":"crossref","first-page":"953","DOI":"10.1016\/S0891-5849(98)00184-1","article-title":"Nitrotyrosine in plasma of celiac disease patients as detected by a new sandwich ELISA","volume":"25","author":"Forget","year":"1998","journal-title":"Free Radic. Biol. Med."},{"key":"ref_47","doi-asserted-by":"crossref","first-page":"782","DOI":"10.1097\/01.mcg.0000177240.67215.da","article-title":"Serum nitric oxide levels in children with celiac disease","volume":"39","author":"Ertekin","year":"2005","journal-title":"J. Clin. Gastroenterol."},{"key":"ref_48","doi-asserted-by":"crossref","first-page":"528","DOI":"10.1111\/j.1651-2227.1999.tb00169.x","article-title":"Increased urinary nitric oxide oxidation products in children with active coeliac disease","volume":"88","author":"Forget","year":"1999","journal-title":"Acta Paediatr."},{"key":"ref_49","doi-asserted-by":"crossref","first-page":"1023","DOI":"10.1111\/j.1651-2227.2011.02186.x","article-title":"Children with screening-detected coeliac disease show increased levels of nitric oxide products in urine","volume":"100","author":"Webb","year":"2011","journal-title":"Acta Paediatr."},{"key":"ref_50","first-page":"196","article-title":"Significantly increased levels of nitric oxide products in urine of children with celiac disease","volume":"27","author":"Sundqvist","year":"1998","journal-title":"J. Pediatr. Gastroenterol. Nutr."},{"key":"ref_51","doi-asserted-by":"crossref","first-page":"537","DOI":"10.1258\/000456307782268075","article-title":"Antioxidant enzymes, glutathione and lipid peroxidation in peripheral blood of children affected by coeliac disease","volume":"44","year":"2007","journal-title":"Ann. Clin. Biochem."},{"key":"ref_52","doi-asserted-by":"crossref","first-page":"7","DOI":"10.1080\/10715769800300031","article-title":"Oxidative stress in subjects affected by celiac disease","volume":"29","author":"Odetti","year":"1998","journal-title":"Free Radic. Res."},{"key":"ref_53","doi-asserted-by":"crossref","first-page":"68","DOI":"10.1159\/000177752","article-title":"Increased susceptibility to undergo lipid peroxidation of chylomicrons and low-density lipoprotein in celiac disease","volume":"37","author":"Lavy","year":"1993","journal-title":"Ann. Nutr. Metab."},{"key":"ref_54","doi-asserted-by":"crossref","first-page":"1960","DOI":"10.1158\/1055-9965.EPI-10-0295","article-title":"Oxidatively damaged DNA\/oxidative stress in children with celiac disease","volume":"19","author":"Siomek","year":"2010","journal-title":"Cancer Epidemiol. Biomark. Prev."},{"key":"ref_55","first-page":"593","article-title":"Vitamin E levels in patients with celiac disease","volume":"7","author":"Hozyasz","year":"2003","journal-title":"Med. Wieku Rozwoj."},{"key":"ref_56","doi-asserted-by":"crossref","first-page":"730","DOI":"10.1016\/j.freeradbiomed.2007.05.003","article-title":"Paraoxonases are associated with intestinal inflammatory diseases and intracellularly localized to the endoplasmic reticulum","volume":"43","author":"Rothem","year":"2007","journal-title":"Free Radic. Biol. Med."},{"key":"ref_57","doi-asserted-by":"crossref","first-page":"63","DOI":"10.1007\/s00210-003-0771-y","article-title":"Gliadin increases iNOS gene expression in interferon\u2014Stimulated RAW 264.7 cells through a mechanism involving NF-\u03baB","volume":"368","author":"Maiuri","year":"2003","journal-title":"Naunyn Schmiedebergs Arch. Pharmacol."},{"key":"ref_58","doi-asserted-by":"crossref","first-page":"65","DOI":"10.1007\/s00109-005-0713-x","article-title":"The role of NF-\u03baB, IRF-1, and STAT-1\u03b1 transcription factors in the iNOS gene induction by gliadin and IFN-\u03b3in RAW 264.7 macrophages","volume":"84","author":"Maiuri","year":"2006","journal-title":"J. Mol. Med."},{"key":"ref_59","doi-asserted-by":"crossref","first-page":"2512","DOI":"10.4049\/jimmunol.176.4.2512","article-title":"Gliadin stimulation of murine macrophage inflammatory gene expression and intestinal permeability are MyD88-dependent: Role of the innate immune response in celiac disease","volume":"176","author":"Thomas","year":"2006","journal-title":"J. Immunol."},{"key":"ref_60","doi-asserted-by":"crossref","first-page":"1400","DOI":"10.1053\/j.gastro.2005.07.054","article-title":"Unexpected role of surface transglutaminase type II in celiac disease","volume":"129","author":"Maiuri","year":"2005","journal-title":"Gastroenterology"},{"key":"ref_61","doi-asserted-by":"crossref","first-page":"311","DOI":"10.1136\/gut.2009.183608","article-title":"Lysosomal accumulation of gliadin p31e43 peptide induces oxidative stress and tissue transglutaminase-mediated PPARg downregulation in intestinal epithelial cells and coeliac mucosa","volume":"59","author":"Luciani","year":"2010","journal-title":"Gut"},{"key":"ref_62","first-page":"1730","article-title":"Do gliadin and tissue transglutaminase mediate PPAR downregulation in intestinal cells of patients with coeliac disease?","volume":"59","author":"Simula","year":"2010","journal-title":"Gut"},{"key":"ref_63","doi-asserted-by":"crossref","first-page":"199","DOI":"10.2119\/molmed.2009.00173","article-title":"PPAR signaling pathway and cancer-related proteins are involved in celiac disease-associated tissue damage","volume":"16","author":"Simula","year":"2010","journal-title":"Mol. Med."},{"key":"ref_64","doi-asserted-by":"crossref","first-page":"373","DOI":"10.1007\/s00109-003-0440-0","article-title":"Nuclear factor kappa B is activated in small intestinal mucosa of celiac patients","volume":"81","author":"Maiuri","year":"2003","journal-title":"J. Mol. Med."},{"key":"ref_65","doi-asserted-by":"crossref","first-page":"1115","DOI":"10.1016\/S0891-5849(96)00501-1","article-title":"Redox regulation of NF-\u03baB activation","volume":"22","author":"Saliou","year":"1997","journal-title":"Free Radic. Biol. Med."},{"key":"ref_66","doi-asserted-by":"crossref","first-page":"6677","DOI":"10.1016\/S0021-9258(18)53303-2","article-title":"Cooperative interaction between interferon (IFN) stimulus response element and kappa B sequence motifs controls IFN gamma- and lipopolysaccharide-stimulated transcription from the murine IP 10 promoter","volume":"268","author":"Ohmori","year":"1993","journal-title":"J. Biol. Chem."},{"key":"ref_67","doi-asserted-by":"crossref","first-page":"541","DOI":"10.1016\/j.clnu.2011.02.007","article-title":"Docosahexaenoic acid modulates in vitro the inflammation of celiac disease in intestinal epithelial cells via the inhibition of cPLA2","volume":"30","author":"Vincentini","year":"2011","journal-title":"Clin. Nutr."},{"key":"ref_68","doi-asserted-by":"crossref","first-page":"173","DOI":"10.1016\/0009-8981(94)90201-1","article-title":"Gamma-type gliadins cause secretion of prostaglandin E2 in patients with coeliac disease","volume":"231","author":"Friis","year":"1994","journal-title":"Clin. Chim. Acta"},{"key":"ref_69","doi-asserted-by":"crossref","first-page":"249","DOI":"10.1016\/j.jaut.2003.12.001","article-title":"cDNA microarray analysis of gene expression in coeliac disease jejunal biopsy samples","volume":"22","author":"Kaukinen","year":"2004","journal-title":"J. Autoimmun."},{"key":"ref_70","doi-asserted-by":"crossref","first-page":"294","DOI":"10.1111\/j.1365-2249.2007.03500.x","article-title":"Gluten affects epithelial differentiation-associated genes in small intestinal mucosa of coeliac patients","volume":"150","author":"Kainulainen","year":"2007","journal-title":"Clin. Exp. Immunol."},{"key":"ref_71","doi-asserted-by":"crossref","first-page":"320","DOI":"10.1034\/j.1399-3038.2003.00053.x","article-title":"Working Group of the SIGEP; Working Group of \u201cClub del Tenue\u201d. Plasma cytokine profiles in patients with celiac disease and selective IgA deficiency","volume":"14","author":"Cataldo","year":"2003","journal-title":"Pediatr. Allergy Immunol."},{"key":"ref_72","doi-asserted-by":"crossref","first-page":"50","DOI":"10.1016\/j.ejphar.2011.05.085","article-title":"Fatty acids and inflammation: The cutting edge between food and pharma","volume":"668","author":"Calder","year":"2011","journal-title":"Eur. J. Pharmacol."},{"key":"ref_73","doi-asserted-by":"crossref","first-page":"813","DOI":"10.1172\/JCI107620","article-title":"Enhancement of random migration and chemotactic response of human leukocytes by ascorbic acid","volume":"53","author":"Goetzl","year":"1974","journal-title":"J. Clin. Invest."},{"key":"ref_74","doi-asserted-by":"crossref","first-page":"348","DOI":"10.2174\/1871530311006040348","article-title":"Isoforms of vitamin E differentially regulate inflammation","volume":"10","author":"McCary","year":"2010","journal-title":"Endocr. Metab. Immune Disord. Drug Targets"},{"key":"ref_75","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1016\/j.aller.2010.11.003","article-title":"Ascorbate-dependent decrease of the mucosal immune inflammatory response to gliadin in coeliac disease patients","volume":"40","author":"Bernardo","year":"2012","journal-title":"Allergol. Immunopathol."},{"key":"ref_76","doi-asserted-by":"crossref","first-page":"2178","DOI":"10.1111\/j.1476-5381.1996.tb15660.x","article-title":"Inhibition by antioxidants of nitric oxide synthase expression in murine macrophages: Role of nuclear factor kappa B and interferon regulatory factor 1","volume":"118","author":"Hecker","year":"1996","journal-title":"Br. J. Pharmacol."},{"key":"ref_77","doi-asserted-by":"crossref","first-page":"920","DOI":"10.1177\/153537020222701013","article-title":"Overview of mechanisms of action of lycopene","volume":"227","author":"Heber","year":"2002","journal-title":"Exp. Biol. Med."},{"key":"ref_78","doi-asserted-by":"crossref","first-page":"337","DOI":"10.1016\/S0024-3205(99)00120-4","article-title":"Flavonoids: Old and new aspects of a class of natural therapeutic drugs","volume":"65","author":"Mascolo","year":"1999","journal-title":"Life Sci."},{"key":"ref_79","doi-asserted-by":"crossref","first-page":"192","DOI":"10.1016\/j.ejphar.2007.03.051","article-title":"Lycopene, quercetin and tyrosol prevent macrophage activation induced by gliadin and IFN-gamma","volume":"566","author":"Maiuri","year":"2007","journal-title":"Eur. J. Pharmacol."},{"key":"ref_80","doi-asserted-by":"crossref","first-page":"401","DOI":"10.1016\/j.jnutbio.2010.08.001","article-title":"Role of flavonoids in intestinal tight junction regulation","volume":"22","author":"Suzuki","year":"2011","journal-title":"J. Nutr. Biochem."},{"key":"ref_81","doi-asserted-by":"crossref","first-page":"16683","DOI":"10.1074\/jbc.M011695200","article-title":"Saturated fatty acids, but not unsaturated fatty acids, induce the expression of cyclooxygenase-2 mediated through Toll-like receptor 4","volume":"276","author":"Lee","year":"2001","journal-title":"J. Biol. Chem."},{"key":"ref_82","doi-asserted-by":"crossref","first-page":"1172","DOI":"10.1189\/jlb.1007688","article-title":"Human dendritic cell activities are modulated by the omega-3 fatty acid, docosahexaenoic acid, mainly through PPAR(gamma):RXR heterodimers: Comparison with other polyunsaturated fatty acids","volume":"84","author":"Rueda","year":"2008","journal-title":"J. Leukoc. Biol."},{"key":"ref_83","doi-asserted-by":"crossref","first-page":"541","DOI":"10.1016\/j.clnu.2011.02.007","article-title":"Docosahexaenoic acid modulates in vitro the inflammation of celiac disease in intestinal epithelial cells via the inhibition of cPLA2","volume":"30","author":"Vincentini","year":"2011","journal-title":"Clin. Nutr."}],"container-title":["Nutrients"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.mdpi.com\/2072-6643\/4\/4\/243\/pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,10,11]],"date-time":"2025-10-11T21:49:34Z","timestamp":1760219374000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.mdpi.com\/2072-6643\/4\/4\/243"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2012,3,27]]},"references-count":83,"journal-issue":{"issue":"4","published-online":{"date-parts":[[2012,4]]}},"alternative-id":["nu4040243"],"URL":"https:\/\/doi.org\/10.3390\/nu4040243","relation":{},"ISSN":["2072-6643"],"issn-type":[{"value":"2072-6643","type":"electronic"}],"subject":[],"published":{"date-parts":[[2012,3,27]]}}}